Galectin-3 inhibition prevents adipose tissue remodelling in obesity

39Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Extracellular matrix remodelling of the adipose tissue has a pivotal role in the pathophysiology of obesity. Galectin-3 (Gal-3) is increased in obesity and mediates inflammation and fibrosis in the cardiovascular system. However, the effects of Gal-3 on adipose tissue remodelling associated with obesity remain unclear. Male Wistar rats were fed either a high-fat diet (33.5% fat) or a standard diet (3.5% fat) for 6 weeks. Half of the animals of each group were treated with the pharmacological inhibitor of Gal-3, modified citrus pectin (MCP; 100 mg kg -1 per day) in the drinking water. In adipose tissue, obese animals presented an increase in Gal-3 levels that were accompanied by an increase in pericellular collagen. Obese rats exhibited higher adipose tissue inflammation, as well as enhanced differentiation degree of the adipocytes. Treatment with MCP prevented all the above effects. In mature 3T3-L1 adipocytes, Gal-3 (10 -8 m) treatment increased fibrosis, inflammatory and differentiation markers. In conclusion, Gal-3 emerges as a potential therapeutic target in adipose tissue remodelling associated with obesity and could have an important role in the development of metabolic alterations associated with obesity.

Cite

CITATION STYLE

APA

Martínez-Martínez, E., Calvier, L., Rossignol, P., Rousseau, E., Fernández-Celis, A., Jurado-López, R., … López-Andrés, N. (2016). Galectin-3 inhibition prevents adipose tissue remodelling in obesity. International Journal of Obesity, 40(6), 1034–1038. https://doi.org/10.1038/ijo.2016.19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free